WithdrawnPhase 2

A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

Stopped: Cancelled before first patient enrolled

0Started 2007-06

Plain-language summary

This study will evaluate the safety and efficacy of AG-014699 in diabetic patients

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diabetic patients, either man or woman, with diabetic retinopathy, at least 18 years of age Exclusion Criteria: * patients treated with laser therapy within the last 90 days * patients with likelyhood to require cataract surgery within 3 months * Uncontrolled diabetes

What they're measuring

Change of retinal thickness at Day 15 or Day 25 depending on dosing regimen

Trial details

NCT IDNCT00457470

SponsorPfizer

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Diabetes Mellitus trials